These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31933902)

  • 1. Comparative analysis of colorectal mixed adenoneuroendocrine carcinoma and adenocarcinoma with neuroendocrine differentiation: a population-based study.
    Song LJ; Yuan L
    Int J Clin Exp Pathol; 2019; 12(3):922-932. PubMed ID: 31933902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed adenoneuroendocrine carcinoma originating from the appendix and colorectum: a comparative analysis of a large population-based database.
    Zhao B; Wang J; Ye H; Cheng X; Meng K; Yang T
    Tech Coloproctol; 2023 Nov; 27(11):1017-1024. PubMed ID: 36995458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Clinicopathological Features of Biliary Neuroendocrine Carcinoma with Adenocarcinoma.
    Shiihara M; Higuchi R; Furukawa T; Yazawa T; Uemura S; Izumo W; Yamamoto M
    Dig Surg; 2021; 38(1):30-37. PubMed ID: 32570243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive Phenotypic and Microenvironmental Characteristics of Neuroendocrine Carcinoma and Adenocarcinoma Components in Gastric Mixed Adenoneuroendocrine Carcinoma.
    Kwak Y; Nam SK; Park Y; Suh YS; Ahn SH; Kong SH; Park DJ; Lee HJ; Kim HH; Yang HK; Lee HS
    Mod Pathol; 2024 Oct; 37(10):100568. PubMed ID: 39029904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
    Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
    Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of survival outcomes and survival prediction in patients with primary colorectal MANEC and primary colorectal SRCC: a population-based propensity-score matching study.
    Zhu Y; Thandar M; Cheng J; Zhang X; Zhao Z; Huang S; Chi P
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):13279-13300. PubMed ID: 37481754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile and predictors.
    Onyemkpa C; Davis A; McLeod M; Oyasiji T
    J Gastrointest Oncol; 2019 Apr; 10(2):300-306. PubMed ID: 31032098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal mixed adenoneuroendocrine carcinoma: a population level analysis of epidemiological trends.
    Wang J; He A; Feng Q; Hou P; Wu J; Huang Z; Xiao Z; Sun C; Liao W; Wu L
    J Transl Med; 2020 Mar; 18(1):128. PubMed ID: 32169074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological characteristics and prognosis analysis of colorectal neuroendocrine neoplasms based on the data from domestic six medical centers].
    Zhang Y; Peng X; Jin K; Wang W; Feng X; Zeng Y; Chen M; Yu X; Chen Y; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1235-1240. PubMed ID: 27928792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series.
    Dulskas A; Pilvelis A
    Eur J Surg Oncol; 2020 Jan; 46(1):105-107. PubMed ID: 31444026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed adenoneuroendocrine carcinoma: A review of pathologic characteristics.
    Brathwaite SA; Smith SM; Wai L; Frankel W; Hays J; Yearsley MM; Abdel-Misih S
    Hum Pathol; 2018 Mar; 73():184-191. PubMed ID: 29288693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed Adeno-neuroendocrine Carcinoma: An Aggressive Clinical Entity.
    Brathwaite S; Rock J; Yearsley MM; Bekaii-Saab T; Wei L; Frankel WL; Hays J; Wu C; Abdel-Misih S
    Ann Surg Oncol; 2016 Jul; 23(7):2281-6. PubMed ID: 26965701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
    Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
    Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin.
    Litmeyer AS; Konukiewitz B; Kasajima A; Foersch S; Schicktanz F; Schmitt M; Kellers F; Grass A; Jank P; Lehman B; Gress TM; Rinke A; Bartsch DK; Denkert C; Weichert W; Klöppel G; Jesinghaus M
    J Pathol Clin Res; 2023 Nov; 9(6):498-509. PubMed ID: 37608427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastric mixed adenoneuroendocrine carcinoma: a clinicopathological analysis of 36 cases].
    Gao R; Chen XY; Jin L
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):767-771. PubMed ID: 31594040
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
    Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis, Assessment, and Therapeutic Strategy for Colorectal Mixed Adenoneuroendocrine Carcinoma.
    Tanaka T; Kaneko M; Nozawa H; Emoto S; Murono K; Otani K; Sasaki K; Nishikawa T; Kiyomatsu T; Hata K; Morikawa T; Kawai K; Watanabe T
    Neuroendocrinology; 2017; 105(4):426-434. PubMed ID: 28641295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
    Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM
    BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine-nonneuroendocrine neoplasm.
    Sun L; Zhang J; Wang C; Zhao S; Shao B; Guo Y; Liu Y; Sun Y
    Mod Pathol; 2020 Dec; 33(12):2602-2613. PubMed ID: 32461621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed adenoneuroendocrine carcinoma (MANEC) of the lower gastrointestinal tract: A systematic review with Bayesian hierarchical survival analysis.
    Grossi U; Bonis A; Carrington EV; Mazzobel E; Santoro GA; Cattaneo L; Centonze G; Gallo G; Kazemi Nava A; Romano M; Di Tanna GL; Zanus G
    Eur J Surg Oncol; 2021 Nov; 47(11):2893-2899. PubMed ID: 34052038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.